These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 13655031)

  • 1. A chemical and pharmacological investigation of Piper methysticum Forst.
    KLOHS MW; KELLER F; WILLIAMS RE; TOEKES MI; CRONHEIM GE
    J Med Pharm Chem; 1959 Feb; 1(1):95-103. PubMed ID: 13655031
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacology of the active principles of kavaroot (Piper methysticum Forst)].
    MEYER HJ
    Arch Int Pharmacodyn Ther; 1962 Aug; 138():505-36. PubMed ID: 13935274
    [No Abstract]   [Full Text] [Related]  

  • 3. [A drug from Polynesia with central nervous activity: Piper methysticum Forst ("kawa-kawa")].
    REALDON E
    Gazz Med Ital; 1960 Jun; 119():231-3. PubMed ID: 14436715
    [No Abstract]   [Full Text] [Related]  

  • 4. Quantitative elimination of Flavokavines A and B from Kava Kava (Piper methysticum G. Forst) by isoelectric focused adsorptive bubble separation.
    Backleh M; Ekici P; Leupold G; Parlar H
    Naturwissenschaften; 2003 Aug; 90(8):366-9. PubMed ID: 12955226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of cytochrome P450 3A4 by extracts and kavalactones of Piper methysticum (Kava-Kava).
    Unger M; Holzgrabe U; Jacobsen W; Cummins C; Benet LZ
    Planta Med; 2002 Dec; 68(12):1055-8. PubMed ID: 12494328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Traditional preparations of kava (Piper methysticum) inhibit the growth of human colon cancer cells in vitro.
    Einbond LS; Negrin A; Kulakowski DM; Wu HA; Antonetti V; Jalees F; Law W; Roller M; Redenti S; Kennelly EJ; Balick MJ
    Phytomedicine; 2017 Jan; 24():1-13. PubMed ID: 28160848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, in vitro, reactivity, and identification of 6-phenyl-3-hexen-2-one in human urine after kava-kava (Piper methysticum) ingestion.
    Zou L; Harkey MR; Henderson GL
    Planta Med; 2005 Feb; 71(2):142-6. PubMed ID: 15729622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of plant extracts by NIRS: simultaneous determination of kavapyrones and water in dry extracts of Piper methysticum Forst.
    Gaub M; Roeseler Ch; Roos G; Kovar KA
    J Pharm Biomed Anal; 2004 Nov; 36(4):859-64. PubMed ID: 15533680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracts and kavalactones of Piper methysticum G. Forst (kava-kava) inhibit P-glycoprotein in vitro.
    Weiss J; Sauer A; Frank A; Unger M
    Drug Metab Dispos; 2005 Nov; 33(11):1580-3. PubMed ID: 16051732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of various Piper methysticum cultivars with CNS receptors in vitro.
    Dinh LD; Simmen U; Bueter KB; Bueter B; Lundstrom K; Schaffner W
    Planta Med; 2001 Jun; 67(4):306-11. PubMed ID: 11458444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Final report on the safety assessment of Piper methysticum leaf/root/stem extract and Piper methysticum root extract.
    Robinson V; Bergfeld WF; Belsito DV; Klaassen CD; Marks JG; Shank RC; Slaga TJ; Snyder PW; ; Andersen FA
    Int J Toxicol; 2009; 28(6 Suppl):175S-88S. PubMed ID: 19966149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kava Hepatotoxicity: Are we any closer to the truth?
    Anke J; Ramzan I
    Planta Med; 2004 Mar; 70(3):193-6. PubMed ID: 15114493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kava: an overview.
    Singh YN
    J Ethnopharmacol; 1992 Aug; 37(1):13-45. PubMed ID: 1453702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic and pharmacodynamic drug interactions with Kava (Piper methysticum Forst. f.).
    Anke J; Ramzan I
    J Ethnopharmacol; 2004 Aug; 93(2-3):153-60. PubMed ID: 15234747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-performance liquid chromatography-coordination ion spray-mass spectrometry (HPLC-CIS/MS): a new tool for the analysis of non-polar compound classes in plant extracts using the example of Piper methysticum Forst.
    Gaub M; von Brocke A; Roos G; Kovar KA
    Phytochem Anal; 2004; 15(5):300-5. PubMed ID: 15508834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute oral toxicity, antinociceptive and antimicrobial activities of kava dried extracts and synthetic kavain.
    Ferreira JV; Pierotte IC; Rodrigues FF; Souza LCR; Bastos RW; Carmo PHF; Cassali GD; Tagliati CA; Machado RR; Santos DA; Pianetti GA; César IC
    Nat Prod Res; 2022 Aug; 36(16):4221-4226. PubMed ID: 34491148
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of novel electrophilic metabolites of piper methysticum Forst (Kava).
    Johnson BM; Qiu SX; Zhang S; Zhang F; Burdette JE; Yu L; Bolton JL; van Breemen RB
    Chem Res Toxicol; 2003 Jun; 16(6):733-40. PubMed ID: 12807356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CENTRAL ACTIVITY OF AQUEOUS EXTRACTS OF PIPER METHYSTICUM (KAVA).
    FURGIUELE AR; KINNARD WJ; ACETO MD; BUCKLEY JP
    J Pharm Sci; 1965 Feb; 54():247-52. PubMed ID: 14293812
    [No Abstract]   [Full Text] [Related]  

  • 19. Piper methysticum (kava kava).
    Altern Med Rev; 1998 Dec; 3(6):458-60. PubMed ID: 9855570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of traditional kava (Piper methysticum) use on cognition: Implications for driver fitness.
    Aporosa S'; Ballard H; Pandey R; McCarthy MJ
    J Ethnopharmacol; 2022 Jun; 291():115080. PubMed ID: 35151837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.